Related Experiment Video
Updated: Jun 15, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders
Christina Sun1, Andreea Temelie1, Hannah Goulding1
1UPMC Western Psychiatric Hospital, Pittsburgh, Pennsylvania, USA.
This study examined long-acting injectable antipsychotics (LAIAs) in child and adolescent psychiatric inpatients. Findings reveal dosing variations from adult guidelines and significant readmission rates, highlighting the need for further research.
Area of Science:
- Child and Adolescent Psychiatry
- Pharmacology
- Clinical Research
Background:
- Long-acting injectable antipsychotics (LAIAs) are not FDA-approved for pediatric use but are prescribed off-label.
- Limited data exists on LAIA initiation and dosing in child and adolescent populations.
Purpose of the Study:
- To describe the initiation and maintenance dosing strategies of LAIAs in pediatric psychiatric inpatients.
- To analyze patient demographics and diagnoses associated with LAIA use in this age group.
Main Methods:
- Retrospective chart review of patients under 18 initiated on LAIAs during hospitalization.
- Data collection included demographics, diagnoses, LAIA agents, dosing regimens, length of stay, and readmission rates.
- Descriptive statistics were used for analysis.
Main Results:
- 45 (0.7%) of 6402 pediatric patients were initiated on LAIAs, with an average age of 15.6 years.
- Paliperidone palmitate and aripiprazole monohydrate were the most common LAIAs prescribed for diagnoses including psychotic and bipolar disorders.
- 17 patients (37.8%) received doses differing from adult package inserts, and 31.1% were readmitted within 6 months.
Conclusions:
- This is the first study to detail LAIA dosing strategies in pediatric inpatients.
- Dosing often deviates from adult recommendations, and readmission rates are notable.
- Further research is needed to assess LAIA efficacy and impact on clinical outcomes in children and adolescents.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Mania and Antimanic Drugs: Overview

